These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 15507757

  • 1. Intravenous immunoglobulin (IVIg) therapy in MPO-ANCA related polyangiitis with rapidly progressive glomerulonephritis in Japan.
    Muso E, Ito-Ihara T, Ono T, Imai E, Yamagata K, Akamatsu A, Suzuki K.
    Jpn J Infect Dis; 2004 Oct; 57(5):S17-8. PubMed ID: 15507757
    [Abstract] [Full Text] [Related]

  • 2. Clinical efficacy of intravenous immunoglobulin for patients with MPO-ANCA-associated rapidly progressive glomerulonephritis.
    Ito-Ihara T, Ono T, Nogaki F, Suyama K, Tanaka M, Yonemoto S, Fukatsu A, Kita T, Suzuki K, Muso E.
    Nephron Clin Pract; 2006 Oct; 102(1):c35-42. PubMed ID: 16174989
    [Abstract] [Full Text] [Related]

  • 3. [Therapeutic effect and clinical findings in patients with MPO-ANCA associated vasculitis syndrome].
    Yoshida A, Takeda A, Fukuda M, Toda S, Morozumi K.
    Ryumachi; 2000 Feb; 40(1):1-8. PubMed ID: 10783659
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. MPO-ANCA-associated pulmonary-renal vasculitis in a patient with diabetes mellitus.
    Keven K, Akar H, Kutlay S, Nergizoglu G, Erbay B, Erturk S.
    J Nephrol; 2002 Feb; 15(6):720-3. PubMed ID: 12495292
    [Abstract] [Full Text] [Related]

  • 6. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane.
    Lindic J, Vizjak A, Ferluga D, Kovac D, Ales A, Kveder R, Ponikvar R, Bren A.
    Ther Apher Dial; 2009 Aug; 13(4):278-81. PubMed ID: 19695059
    [Abstract] [Full Text] [Related]

  • 7. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
    Rutgers A, Slot M, van Paassen P, van Breda Vriesman P, Heeringa P, Tervaert JW.
    Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
    [Abstract] [Full Text] [Related]

  • 8. Improvements in treatment strategies for patients with antineutrophil cytoplasmic antibody-associated rapidly progressive glomerulonephritis.
    Hotta O, Ishida A, Kimura T, Taguma Y.
    Ther Apher Dial; 2006 Oct; 10(5):390-5. PubMed ID: 17096692
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of prognostic factors for myeloperoxidase anti-neutrophil cytoplasmic antibody- (MPO-ANCA) associated glomerulonephritis.
    Okano K, Yumura W, Nitta K, Honda K, Uchida K, Nihei H.
    Clin Nephrol; 2001 Apr; 55(4):275-81. PubMed ID: 11334312
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunosuppressive therapy and clinical evolution in forty-nine patients with antineutrophil cytoplasmic antibody-associated glomerulonephritis.
    Kokolina E, Alexopoulos E, Dimitriadis C, Vainas A, Giamalis P, Papagianni A, Ekonomidou D, Memmos D.
    Ann N Y Acad Sci; 2005 Jun; 1051():597-605. PubMed ID: 16127000
    [Abstract] [Full Text] [Related]

  • 13. Autopsy case of microscopic polyangiitis with crescentic glomerulonephritis and necrotizing pancreatitis.
    Iwasa S, Katoh R.
    Pathol Int; 2005 Aug; 55(8):520-3. PubMed ID: 15998382
    [Abstract] [Full Text] [Related]

  • 14. Cytapheresis for the treatment of myeloperoxidase antineutrophil cytoplasmic autoantibody-associated vasculitis: a pilot study of 21 patients.
    Hasegawa M, Ohashi A, Kabutan N, Hiramatsu S, Kato M, Murakami K, Tomita M, Nabeshima K, Hiki Y, Sugiyama S.
    Ther Apher Dial; 2006 Oct; 10(5):412-8. PubMed ID: 17096695
    [Abstract] [Full Text] [Related]

  • 15. IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis.
    Liu LJ, Chen M, Yu F, Zhao MH, Wang HY.
    Nephrology (Carlton); 2008 Oct; 13(7):629-35. PubMed ID: 18775059
    [Abstract] [Full Text] [Related]

  • 16. Systemic granulomatous necrotizing vasculitis in a MPO-ANCA-positive patient.
    Kurata A, Nishimura Y, Yamato T, Arimura Y, Yamada A, Sakamoto A, Fujioka Y.
    Pathol Int; 2004 Aug; 54(8):636-40. PubMed ID: 15260856
    [Abstract] [Full Text] [Related]

  • 17. Follow-up of avidity and titre of anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis.
    Gao Y, Chen M, Ye H, Guo XH, Zhao MH, Wang HY.
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):543-7. PubMed ID: 17371473
    [Abstract] [Full Text] [Related]

  • 18. Apheresis for MPO-ANCA-associated RPGN-indications and efficacy: lessons learned from Japan nationwide survey of RPGN.
    Yamagata K, Hirayama K, Mase K, Yamaguchi N, Kobayashi M, Takahashi H, Koyama A.
    J Clin Apher; 2005 Dec; 20(4):244-51. PubMed ID: 15880406
    [Abstract] [Full Text] [Related]

  • 19. Long-term treatment results and the immunoglobulin G subclass distribution patterns of proteinase-3-antineutrophil cytoplasm antibody (ANCA) and myeloperoxidase-ANCA in ANCA-associated vasculitis.
    Almroth G, Berlin G, Andersson B, Hahn-Zoric M.
    Scand J Urol Nephrol; 2009 Dec; 43(2):160-70. PubMed ID: 18979374
    [Abstract] [Full Text] [Related]

  • 20. Four cases of anti-myeloperoxidase antibody-related rapidly progressive glomerulonephritis during the course of idiopathic pulmonary fibrosis.
    Hiromura K, Nojima Y, Kitahara T, Ueki K, Maezawa A, Kawai H, Yano S, Naruse T.
    Clin Nephrol; 2000 May; 53(5):384-9. PubMed ID: 11305812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.